World Anti-Doping Code Commentary Project

The first fully comprehensive resource for anti-doping practitioners, providing guidance along all steps of the doping control process. With topics ranging from signatory compliance to application of the sanctioning regime, the commentary will assist the anti-doping movement to achieve a more effective implementation and harmonized interpretation of the 2015 World Anti-Doping Code.

Medications

/Tag:Medications
­

Meldonium and Moral Fault: Five Lessons Learned from the Sharapova ITF Tribunal Decision

In Fall 2015, WADA announced its decision to add the anti-ischemic drug “Meldonium” to its Prohibited List with effect on 1 January 2016, after the Monitoring Program and observation period 2015 revealed “evidence of its use by athletes with the intention of enhancing performance” (Explanatory Notice to the 2016 List). Few observers could have predicted [...]

The ISSF v. WADA CAS Award: Another Therapeutic Use Exemption Request for Beta Blockers Shot Down

CAS Award: CAS 2013/A/3437, International Shooting Sport Federation v. WADA,  December 18, 2014. The granting of Therapeutic Use Exemptions (“TUE”) is an important aspect of an Anti-Doping Organization’s daily activities. It is also the only way for Athletes to receive medical treatment while staying active in competitive sport when they are obliged, for therapeutic reasons [...]

By |August 10th, 2015|Therapeutic Use Exemptions|0 Comments

The Stewart CAS Award: “Paperwork” Violations and Principles Surrounding “Retrospective” Therapeutic Use Exemptions

CAS Award: CAS 2014/A/3876, Stewart v. FIM, April 27, 2015. FACTS James Stewart, a professional motocross and supercross rider, had been regularly taking the medication “Adderall” since 2012,[1] when he underwent an In-Competition Doping Control test on 12 April at the 2014 AMA Supercross FIM World Championship.[2] In May 2014, an analysis of the rider’s [...]